MediFransk ApS: Financial statements 2024
CVR: 40780904
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MediFransk ApS (CVR 40780904) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 806,939 and a net result of DKK 50,715 compared with DKK -14,102 the year before. That is an increase of 97.8% compared with the year before. Equity in the 2024 report amounted to DKK 70,023. The solvency ratio was 32.3%.
- Gross Profit
- DKK 806,939
- Profit/Loss
- DKK 50,715
- Equity
- DKK 70,023
- Total Assets
- DKK 216,901
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 807 t. | 51 t. | 70 t. | - |
| 2023 | - | 408 t. | -14 t. | 19 t. | - |
| 2022 | - | 608 t. | -9 t. | 33 t. | - |
| 2021 | - | 457 t. | 2 t. | 42 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MediFransk ApS has published its annual report for 2023. Gross profit came to DKK 408,013, and the net result was DKK -14,102.
About MediFransk ApS
MediFransk ApS is a Danish company of the type Anpartsselskab based in Ålsgårde, founded in 2019. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Frédéric Pierre Louis Bernard. The company is owned by BERNARD Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 485,515 and a net result of DKK 104,261 compared with DKK 50,715 the year before. Equity in the 2025 report amounted to DKK 174,291.